Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | RORC | P51449 | 1/20 | 0.44 |
| ▸ | FOS | P01100 | 1/20 | 0.42 |
| ▸ | TTR | P02766 | 1/20 | 0.42 |
| ▸ | JUN | P05412 | 1/20 | 0.42 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.41 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31484827 | 0.84 | THRB (0.36) | THRBRORCFOSTTRJUN | |
| SCHEMBL27758290 | 0.83 | TTR (0.42) | THRBRORCFOSTTRJUN | |
| SCHEMBL27930394 | 0.83 | TUBB4A (0.46) | FOSTTRJUNAKR1B1TNKS2 | |
| SCHEMBL29149128 | 0.81 | HSD17B10 (0.35) | THRBRORCFOSTTRJUN | |
| SCHEMBL918818 | 0.81 | FOS (0.39) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL4576587 | 0.81 | PTGS2 (0.59) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL3810245 | 0.77 | CYP3A4 (0.49) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL29022512 | 0.76 | ALDH1A1 (0.38) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL14280291 | 0.76 | ALDH1A1 (0.38) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL14551477 | 0.76 | FOS (0.43) | THRBRORCFOSTTRJUN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504367-A | Preparation method of benvimod | 承德医学院 | 2025-02-25 | — | — | CN | claimed |
| CN-115894186-B | Synthesis method of benvimod intermediate | 济川(上海)医学科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-112851506-B | Industrial preparation method of 3, 5-dimethoxy-4-alkyl benzyl alcohol | 湖北英纳氏生物科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-112661611-B | Preparation method of benzenediol bioactive substance | 武汉英纳氏药业有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-115894186-A | Synthetic method of intermediate of limod | 济川(上海)医学科技有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-112851506-A | Industrial preparation method of 3, 5-dimethoxy, 4-alkyl benzyl alcohol | 湖北英纳氏生物科技有限公司 | 2021-05-28 | — | — | CN | claimed |
| CN-112661611-A | Preparation method of benzenediol bioactive substance | 武汉英纳氏药业有限公司 | 2021-04-16 | — | — | CN | claimed |
| CN-103992212-B | Synthesis method for cis-benvitimod, and applications of cis-benvitimod | UNIV HEBEI SCIENCE & TECH | 2015-07-01 | — | — | CN | claimed |
| US-20260091027-A1 | STILBENE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | THEDERMA SHANGHAI CO LTD (CN) | 2026-04-02 | — | — | US | disclosed |
| EP-4592271-A1 | STILBENE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | Thederma Shanghai Co., Ltd. (CN) | 2025-07-30 | — | — | EP | disclosed |
| WO-2025133100-A1 | PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR THE PREPARATION OF TAPINAROF | INTERQUIM, S.A. (ES) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025099634-A1 | PROCESS FOR PREPARING THE POLYMORPHIC FORM III OF TAPINAROF | PROCOS S.P.A. (IT) | 2025-05-15 | — | — | WO | disclosed |
| CN-119504367-A | Preparation method of benvimod | 承德医学院 | 2025-02-25 | — | — | CN | disclosed |
| CN-119504367-A | Preparation method of benvimod | 承德医学院 | 2025-02-25 | — | — | CN | disclosed |
| US-20050059733-A1 | Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues | WELICHEM BIOTECH, INC. | 2005-03-17 | — | — | US | disclosed |
| US-20040102517-A1 | Modulators of T- cells, neutrophils, macrophages and their associated cytokines | GLAXO GROUP LIMITED (GB) | 2004-05-27 | — | — | US | disclosed |
| US-20030171429-A1 | Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxyltilbenes and novel stilbene derivatives and analogues | WELICHEMBIOTECH INC. (CA) | 2003-09-11 | — | — | US | disclosed |
| CN-1407978-A | Anti-inflammatory, psoriasis treatment and protein kinase inhibition using hydroxystilbenes, novel stilbene derivatives and analogues thereof | GENHUI CHEN (CA) | 2003-04-02 | — | — | CN | disclosed |
| EP-1248774-A2 | POLYHYDROXYSTILBENES AND STILBENE OXIDES AS ANTIPSORIATIC AGENTS AND PROTEIN KINASE INHIBITORS | Welichem Biotech Inc. (CA) | 2002-10-16 | — | — | EP | disclosed |
| WO-2001042231-A2 | POLYHYDROXYSTILBENES AND STILBENE OXIDES AS ANTISORIATIC AGENTS AND PROTEIN KINASE INHIBITORS | WELICHEM BIOTECH INC. (CA) | 2001-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050059733-A1 | Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues | NFKBIA, IKBKB, IKBKE | THRB 2458/4885RORC 438/4885FOS 2936/4885 |
| US-20040102517-A1 | Modulators of T- cells, neutrophils, macrophages and their associated cytokines | IL2, NFATC1, IFNG | THRB 1282/4885RORC 81/4885FOS 883/4885 |
| US-20260091027-A1 | STILBENE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | AHR, CYP1B1, ARNT | THRB 123/4885RORC 343/4885FOS 525/4885 |
| US-20030171429-A1 | Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxyltilbenes and novel stilbene derivatives and analogues | ROCK1, ROCK2, PTK2 | THRB 2024/4885RORC 577/4885FOS 2676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.